Latest return on equity
Monopar Therapeutics Return on equity
Monopar Therapeutics (MNPR) return on equity with its verified observation date.
Direct answer
Monopar Therapeutics's return on equity is -19.5%.
The verified market snapshot reports -19.5%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 27, 2026.
Get free Monopar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -19.5%
Explore related company data
View Monopar Therapeutics's market capitalizationView Monopar Therapeutics's price-to-book ratioView Monopar Therapeutics's 52-week price rangeView Monopar Therapeutics's profit marginView Monopar Therapeutics's debt-to-equity ratioView all Monopar Therapeutics key metricsReturn to Monopar Therapeutics profile